• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN SPIDER FX; CATHETER, CAROTID, TEMPORARY, FOR EMBOLIZATION CAPTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN SPIDER FX; CATHETER, CAROTID, TEMPORARY, FOR EMBOLIZATION CAPTURE Back to Search Results
Catalog Number UNK-PLY-SPIDER
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Embolism (1829); Hematoma (1884); Transient Ischemic Attack (2109); Patient Problem/Medical Problem (2688); Vascular Dissection (3160)
Event Date 05/30/2019
Event Type  Injury  
Manufacturer Narrative
Doi: 10.1097/mca.0000000000000695.Prevalence and predictors of coronary artery disease in patients undergoing carotid artery stenting.Jakub sul¿enko, piotr paluszek, roman machnik, petr widimský, jirí jarkovský and piotr pieniazek.Age or date of birth: average age.Sex: majority gender.Date of event: event date = date of article publication.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Introduction a relationship between carotid stenosis and coronary arterial disease (cad) is widely accepted; however, data on the exact prevalence of coronary disease in patients with severe carotid stenosis are lacking.Information on the prevalence and predictors of cad among these patients could impact diagnostic and treatment approaches.Aim the primary aim of this study was to determine the prevalence of significant cad among patients referred for carotid artery revascularization.The secondary objectives included characterizing the association between the level of advancement of carotid stenosis and the presence of cad, and between atherosclerotic risk factors and the presence of cad in patients with carotid stenosis, and also to determine whether there was a difference in the prevalence of cad between patients with symptomatic versus asymptomatic carotid stenosis.Patients and methods: we included 200 patients with severe carotid stenosis, of whom 77 (38.5%) had symptomatic stenosis.All patients underwent coronary angiography no more than 6 months before the scheduled carotid revascularization.Of the 200 total of patients, 192 underwent carotid stenting, six underwent carotid endarterectomy, and two were treated conservatively.Cad was defined as stenosis of at least 50% on recent coronary angiography or a history of previous percutaneous coronary intervention and/or coronary aortic bypass graft; the prevalence was 77.5% among our patients.There was no statistically significant difference in the prevalence of cad between patients with unilateral versus bilateral carotid stenosis or contralateral carotid occlusion.The difference in the severity of coronary disease, which was given by the syntax score, was not significant between these groups.Factors associated with the presence of cad were male sex,a history of smoking, and global or regional wall motion disorder on echocardiography.We did not find any significant difference in the prevalence of cad between patients with symptomatic versus asymptomatic carotid stenosis.Conclusion we observed a very high prevalence of concomitant cad in patients with severe carotid stenosis.The results of our study suggest that routine preprocedural screening for cad in patients with carotid artery stenosis could identify a large proportion of patients with silent cad; whether treatment for cad before carotid revascularization can prevent periprocedural myocardial infarction should be addressed in a randomized-controlled trial.200 patients with severe carotid stenosis were treated with moma ultra, spider fx, and chrisallo ideale with non-medtronic devices - aim of the study outlined above.The patients presented post procedure with asymptomatic plaque protrusion, treated with post dilation, ica dissection treated with stenting, embolization, ischemic stroke & puncture site bleeding.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPIDER FX
Type of Device
CATHETER, CAROTID, TEMPORARY, FOR EMBOLIZATION CAPTURE
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8774880
MDR Text Key150560136
Report Number2183870-2019-00364
Device Sequence Number1
Product Code NTE
Combination Product (y/n)N
Reporter Country CodeEZ
PMA/PMN Number
K063204
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Other
Type of Report Initial
Report Date 07/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK-PLY-SPIDER
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/17/2019
Initial Date FDA Received07/10/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-